Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency

This resource provides an overview of the “Immediately in Effect Guidance for Clinical Laboratories, Commercial Manufacturers, and Food and Drug Administration Staff,” allowing for the acceleration of COVID-19 diagnostic tests developed by commercial manufacturers and laboratories.
Rate: Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Enter your email address to receive important announcements and updates through the ASPR TRACIE Listserv.